Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-053302
Filing Date
2021-08-25
Accepted
2021-08-25 16:05:54
Documents
2
Period of Report
2021-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3412
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 2433
  Complete submission text file 0001209191-21-053302.txt   7172
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 - 3650 GILMORE WAY BURNABY, A1 V5G 48W
Business Address
KENNEY CHRISTOPHER JOHN (Reporting) CIK: 0001880129 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 211206969